Neuro-immunology experts provide state-of-the-art treatment for patients with Multiple Sclerosis and related diseases. The multidisciplinary program has numerous clinical trials in progress
with highly experienced personnel, including specially trained
physicians and nurses. Yale Neuro-imaging provides advanced imaging and
MRI scanners for MS patients.
In collaboration with Human Translational Immunology in the Department of Immunobiology the members engage in basic research and clinical trials to advance both the understanding of the disorder and continually improve treatment options.
The Program has participated in pivotal trials in many of the currently approved drugs for MS, including glatiramer acetate (Copaxone®), interferons including Avonex®, mitoxantrone (Novantrone®), and natalizumab (Tysabri®).
|
|
Hafler, David, MD, MSc | Gilbert H. Glaser Professor of Neurology and Professor of Immunobiology; Chair, Department of Neurology | (203) 785-5602 Appts
(203) 737-6375 Fax |
|
|
Pelletier, Daniel, MD | Associate Professor of Neurology and of Diagnostic Radiology; Chief, Multiple Sclerosis Center and Neuro-Immunology Division; Director, Yale Clinical Neuroscience Imaging Center (CNIC) | (203) 785-5602 Appts
(203) 737-6375 Fax |
Division Chief
Yale Neurology
800 Howard Avenue
Lower Level
New Haven, CT 06519
Temple Medical Center
40 Temple Street
New Haven, CT 06510